Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
660.00    -5.00 (-0.75%)
Bid:
659.00
Ask:
661.00
Spread: 2.00 (0.303%)
Market Cap: £537.21m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

29 May 2024 07:00

RNS Number : 2363Q
Bloomsbury Publishing PLC
29 May 2024
 

29 May 2024

BLOOMSBURY PUBLISHING PLC 

("Bloomsbury" or "the Company")

Acquisition of Rowman & Littlefield's academic publishing business

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, today announces the acquisition of The Rowman & Littlefield Publishing Group's academic publishing business. It is the biggest acquisition by Bloomsbury to date, and significantly accelerates and strengthens Bloomsbury's academic publishing in North America and Bloomsbury Digital Resources ("BDR").

The transaction is structured as a sale and purchase agreement for the acquisition of certain assets which make up the academic publishing business of The Rowman & Littlefield Publishing Group, Inc. ("Rowman & Littlefield"), the leading independent US trade and academic publisher. The consideration is $83m (£65m), of which $76m (£60m) has been satisfied in cash on completion and up to $7m (£5m), in escrow, will be satisfied in cash post completion.

 

About Rowman & Littlefield

Rowman & Littlefield is a privately-owned independent publisher, founded in 1949. It publishes more than 40,000 academic titles under its greatly respected imprints including Rowman & Littlefield and Lexington Books and prestigious publishing partnerships. Rowman & Littlefield's leading authors cover academic arts, humanities and social sciences, with sales generated through print and ebook.

The transaction does not include Rowman & Littlefield's Globe Pequot lists (with the exception of the Applause and Backbeat imprints), its trade publishing arm, Sundance-Newbridge, its K-8 education business or National Book Network (NBN), its trade distribution business.  

 

Acquisition rationale

This transformational acquisition is a significant milestone in Bloomsbury's 2030 vision, making Bloomsbury a leading US academic publisher. The combined business will publish c97,000 titles, creating a significant platform for further growth, cementing Bloomsbury's strong market position in core subject areas and strengthening areas where the Company is building a presence such as business and psychology. The acquisition will enable us to focus the combined Bloomsbury Academic business on deeper global market penetration, subject area expansion and continued innovation in digital scholarship and learning.

This strategically important acquisition will accelerate BDR, increasing our target revenue for 2027/28 to £41m, as Bloomsbury applies its proven ability to create digital growth to Rowman & Littlefield's market leading titles, expanding BDR products and driving innovation.

Rowman & Littlefield's academic publishing business generated revenue of $36m* (£28m*) and profit before tax of approximately $6m* (£5m*) for the year ended 31 December 2023, with gross assets of approximately $6m* (£5m*).

The acquisition is expected to be earnings accretive, before highlighted items and amortisation, in the current year and significantly earnings accretive, before highlighted items and amortisation, in 2025/26, the first full year. Additionally, there are potential cost synergies from the scale of the combined business and operational improvements.

Bloomsbury has financed this acquisition from its own cash resources and a new $38m (£30m) three year term loan with Lloyds Bank Plc.

The Transaction constitutes a class 2 transaction for the purposes of the UK Financial Authority's Listing Rules and, as such, does not require approval by the Company's shareholders.

Nigel Newton, Chief Executive of Bloomsbury, commented:

"This acquisition is a game-changer for Bloomsbury. Rowman & Littlefield is one of the few independent US academic publishers of such scale and it is great that our discussions with Jed Lyons have led to this acquisition. Their 40,000 academic titles added to ours will make us a significant US academic publisher, growing Bloomsbury's academic and digital publishing presence in North America, opening new markets and publishing areas to Bloomsbury, and is a key milestone in the delivery of our long-term growth strategy. Following the exceptional performance in our Consumer division in our recently announced Preliminary Results, the acquisition accelerates our Non-Consumer division, underlining our portfolio of portfolios strategy."

Jed Lyons, President and CEO of Rowman & Littlefield, commented:

"2024 marks the 75th anniversary of Rowman & Littlefield. When Nigel Newton approached me and described his vision for how our academic businesses would complement Bloomsbury's academic business, it soon became clear that there is a compelling fit. The superb publishing team that runs the Rowman & Littlefield academic business will find a welcoming home at Bloomsbury and our authors will benefit from the global reach of Bloomsbury's sales and marketing efforts."

* These numbers are unaudited.

This announcement contains currency exchange rates based on the average rate on 28 May 2024.

For further information, please contact:

Bloomsbury Publishing Plc

Tamsin Garrity, Head of Investor Relations tamsin.garrity@bloomsbury.com

Hudson Sandler +44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus/ Emily Brooker bloomsbury@hudsonsandler.com

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forwardlooking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forwardlooking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUKVVRSRUVURR
Date   Source Headline
16th May 20087:00 amRNSInterim Management Statement
14th May 20089:06 amRNSDirector/PDMR Shareholding
25th Apr 20084:35 pmRNSDirector/PDMR Shareholding
24th Apr 20083:12 pmRNSDirector/PDMR Shareholding
10th Apr 20083:31 pmRNSHolding(s) in Company
1st Apr 20087:01 amRNSFinal Results
27th Mar 200810:40 amRNSDirector/PDMR Shareholding
11th Mar 200811:53 amRNSHolding(s) in Company
28th Feb 200812:06 pmRNSDirector/PDMR Shareholding
31st Jan 200810:22 amRNSDirector/PDMR Shareholding
22nd Jan 200811:20 amRNSAnnual Information Update
15th Jan 20087:01 amRNSTrading Statement
4th Jan 20085:06 pmRNSDealing by EBT
21st Dec 200711:30 amRNSDirector/PDMR Shareholding
19th Dec 200710:46 amRNSDirector/PDMR Shareholding
23rd Nov 20073:21 pmRNSDirector/PDMR Shareholding
19th Nov 20074:29 pmRNSBlocklisting Interim Review
11th Oct 200712:39 pmRNSHolding(s) in Company
9th Oct 20073:24 pmRNSHolding(s) in Company
8th Oct 20079:21 amRNSDirector/PDMR Shareholding
26th Sep 20074:43 pmRNSDirector appointment
26th Sep 20078:37 amRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSInterim Results
10th Sep 20077:02 amRNSPublishing partnership
5th Sep 20072:08 pmRNSNotice of Results
5th Sep 20077:02 amRNSDirectorate Change
20th Aug 200711:50 amRNSHolding(s) in Company
13th Aug 20079:08 amRNSHolding(s) in Company
7th Aug 20079:58 amRNSHolding(s) in Company
3rd Aug 20072:30 pmRNSFinance Database Partnership
30th Jul 20077:01 amRNSDeathly Hallows
25th Jul 20075:14 pmRNSHolding(s) in Company
23rd Jul 20075:15 pmRNSFirst 24 hour sales
5th Jul 20075:51 pmRNSHolding(s) in Company
2nd Jul 20079:34 amRNSTotal Voting Rights
28th Jun 20071:28 pmRNSResult of AGM
28th Jun 20077:02 amRNSAGM Statement
18th Jun 20079:14 amRNSHolding(s) in Company
4th Jun 20075:08 pmRNSDirector/PDMR Shareholding
29th May 200710:39 amRNSNotice of AGM
18th May 200710:56 amRNSBlocklisting Interim Review
10th May 20075:26 pmRNSDirector/PDMR Shareholding
4th Apr 200711:52 amRNSDirector/PDMR Shareholding
3rd Apr 20077:02 amRNSFinal Results
30th Mar 200710:58 amRNSHolding(s) in Company
29th Mar 20078:54 amRNSHolding(s) in Company
9th Mar 200712:24 pmRNSHolding(s) in Company
6th Mar 20077:00 amRNSHolding(s) in Company
6th Mar 20077:00 amRNSHolding(s) in Company
16th Feb 20079:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.